Human ProIGF-II E (138 – 156) antiserum (Rabbit)

$485.00

Rabbit polyclonal antiserum to human ProIGF-II E (138–156), raised against a 19-amino acid peptide from the C-terminal E domain. Recognises full-length IGF-II E splice variants prior to proteolytic cleavage, with no cross-reactivity to mature IGF-II or IGF-I. May detect IGF-II E proteins in non-human primates. This product is for research use only and not to be used in diagnostic procedures.

Human ProIGF-II E (138-156) antiserum was prepared by immunising rabbits with a 19 amino acid peptide derived from C terminus of the E domain of human IGF-II E linked to diphtheria toxoid. As a consequence, the antiserum recognises full length IGF-II E derived from alternative splicing of the human igf-2 gene before proteolytic cleavage occurs. It does not recognise mature IGF-II or IGF-I. Sequence analysis suggests it is likely to recognise IGF-II E proteins in non-human primates but not other species.

This product is manufactured in Australia by GroPep Bioreagents.

Size	100 µl




Immunogen	Human Pro-IGF-IIE (aa 162-180)
Source Species	Rabbit Polyclonal











Storage	2-8°C

Human ProIGF-II E (138 – 156) antiserum (Rabbit)

Product Citations